GLP-1 Hub
GLP-1 Medications
Five side-by-side comparisons for every major GLP-1 medication decision. Every page covers dosing schedule, average weight loss, common side effects, and cost or access implications.
Try this now — free, no sign-up
Compare projected weight loss between drugs
Runs the same starting-weight input against the pivotal-trial averages for semaglutide (Wegovy) and tirzepatide (Zepbound) so you can see the range published for each medication side by side.
What the result means
The two numbers reflect the trial averages: STEP 1 for semaglutide 2.4 mg over 68 weeks, SURMOUNT-1 for tirzepatide over 72 weeks. They are ranges typical patients saw, not predictions for you specifically.
Limitations
Trial averages describe supervised, adherent patients over a fixed follow-up. Real-world loss is usually a little lower, and the calculator cannot factor in your specific dose response, protein intake or activity.
Educational tool, not medical advice.
Everything in this hub
5 tools and guides grouped by what you're trying to do.
Track your GLP-1 journey
Turn today's number into a real trajectory
Save every dose, weigh-in and symptom in one place. Nothing you enter is sold or shared.
Other GLP-1 hubs
Every other topic in the GLP-1 silo. One click to the section that fits where you are.
Tool Information
August 2026
Dr. Jaydeep Sanghani
Meet Akabari
Dr. Jaydeep Sanghani
MBBS, MD, DNB(Anaesth.), PDCC(CCM), DrNB(CCM)
AIIMS Bhubaneswar · AIIMS Rishikesh
Critical care specialist and anesthesiologist with advanced training from AIIMS. Reviews health calculators at Calqulate to ensure medical accuracy and evidence-based standards.
Educational only
Every tool and guide on this hub is written to help you understand your medication, not to prescribe it. All medical pages are reviewed by a licensed physician. Always confirm your dose, injection schedule and any symptom concerns with your own prescriber and pharmacist.